NRX Pharmaceuticals, Inc.
Recent Filings
All 457 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Javitt Jonathan C | Chairman and Chief Scientist | Purchase | 40,000 @ $1.17 | 84,634 | Dec 17, 2024 |
| Gorovitz Aaron | — | Purchase | 35,000 @ $0.32 | 105,000 | Aug 30, 2023 |
| Hurvitz Chaim | — | Purchase | 70,000 @ $0.29 | 570,000 | Aug 30, 2023 |
| Javitt Jonathan C | Chief Scientist | Purchase | 100,000 @ $0.33 | 446,332 | Aug 23, 2023 |
| Javitt Jonathan C | Chief Scientist | Purchase | 200,000 @ $0.32 | 346,332 | Aug 22, 2023 |
| Willard Stephen H | CHIEF EXECUTIVE OFFICER | Purchase | 50,000 @ $1.17 | 50,000 | Dec 16, 2022 |
| VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Purchase | 30,000 @ $1.10 | 46,337 | Dec 16, 2022 |
| Javitt Jonathan C | — | Sale | 400,000 @ $1.00 | 12,899,997 | Dec 7, 2022 |
| Javitt Daniel C. | — | Sale | 8,441 @ $1.50 | 9,634,793 | Nov 29, 2022 |
| Flynn Patrick John | — | Purchase | 2,500 @ $1.25 | 37,709 | Nov 28, 2022 |